MedPath

A Randomized control trial on primary school children to assess the efficacy of a protein snack with or without micronutrient fortification to promote vitamin B12 status.

Not Applicable
Registration Number
CTRI/2019/01/017075
Lead Sponsor
Mars International India Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Consent

Understanding of the study and willingness to participate as evidenced by subjectâ??s parents and/or legal guardianâ??s voluntary written informed consent as well as written assent by the subject and has received a signed and dated copy of the informed consent form as well as the assent form.

2. Compliance

Understands and is willing, able and likely to comply with all study procedures and restrictions.

3. 20 % of students mildly stunted (height for age Z-scores between -2.0 and -2.9).

Exclusion Criteria

1. Allergy/Intolerance

Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds)

2. Clinical Study/Experimental Medication

Participation in any nutritional study or didactic nutrition education in the last 6 months of the screening visit.

3. Recent history (3 months) of serious infections, injuries and/ or surgeries.

4.Children consuming other nutritional supplements and/ or health food drink on a regular basis in the last 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.vitamin B12 status. <br/ ><br>2.Intestinal microbiota stool sampleTimepoint: Three times during the study. 1. Baseline i.e before start of intervention administration. <br/ ><br>2.1 month post start of intervention. <br/ ><br>3.During End line i.e after the last day of intervention administration.
Secondary Outcome Measures
NameTimeMethod
1.Cognitive functions test. <br/ ><br>2.Anthropometry measurements - height, weight, waist circumference and mid upper arm circumference. <br/ ><br>3. Muscle strength test.Timepoint: Two times during the study. 1. Baseline i.e before start of intervention administration. 2.During End line i.e after the last day of intervention administration.
© Copyright 2025. All Rights Reserved by MedPath